Kyntra Bio, Inc. (KYNB)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Mar 26, 13:31
Kyntra Bio Free Cash Flow : -4.858M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | -28.18M |
| Perspective Therapeutics, Inc. | -95.45M |
| Gossamer Bio, Inc. | -171.34M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.33M |
| Cash from Investing (Quarterly) | -51.71M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow Per Share (Quarterly) | -4.530 |
| Free Cash Flow to Equity (Quarterly) | -16.85M |
| Free Cash Flow to Firm (Quarterly) | -15.92M |
| Free Cash Flow Yield | -2.60% |